LBA27 Phase II multicenter, randomized study to evaluate efficacy and safety of avelumab with gemcitabine/carboplatin (CG) vs CG alone in patients with unresectable or metastatic urothelial carcinoma (mUC) who are ineligible to receive cisplatin-based therapy

• DOI: 10.1016/j.annonc.2020.08.2256
• Publication Date: 2020-09-22T09:17:52Z
• Authors: B. Perez Valderrama; D. Castellano Gauna; A. Pinto Marin; B. Mellado Gonzalez; J. Puente; M.A. Climent Duran; M. Domènech; F.J. Vazquez Mazon; J.L. Perez Gracia; T. Bonfill; R. Morales Barrera; I. Ballester Navarro; X. Garcia del Muro; P. Maroto; O.J. Juan Vidal; A. Rodriguez-Vida; J. Bellmunt
• Keywords: 03 medical and health sciences; 0302 clinical medicine